Scott M. Lippman
62 works · 4,124 citations · h-index 22
Top works
- Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
- 13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin
- Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin
- 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix
- Recent advances in head and neck cancer--larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture.
- Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.
- Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy
- Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration
- The Role of Neck Dissection After Chemoradiotherapy for Oropharyngeal Cancer With Advanced Nodal Disease
- Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis.
- Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions.
- 13-cis-Retinoic Acid Plus Interferon- 2a in Locally Advanced Squamous Cell Carcinoma of the Cervix
- Not yet standard: retinoids versus second primary tumors.
- Retinoic acid and interferon in human cancer: mechanistic and clinical studies.
- Advances in the Development of Retinoids as Chemopreventive Agents
- Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer.
- Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy.
- Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis
- Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
- The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival